Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion type Assertion NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_head.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion evidence source_evidence_literature NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion SIO_000772 2651801 NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion wasDerivedFrom befree-20140225 NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.
- NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_assertion wasGeneratedBy ECO_0000203 NP498881.RAjLdcfV_m0a3yqTc2GXzsfOG7bcBEcui0UzSt27NEeaI130_provenance.